Investigating mTOR as a treatment for neuroendocrine tumours
1 Nov 2010
Investigating mTOR as a treatment for neuroendocrine tumours
Cyberknife robotic radiosurgery
Cancer of unknown primary origin
PARP inhibitors
The ICON7 trial
Care of cancer survivors
Key research from ESMO 2010
The use of pegvisomant to reduce heart rate in acromegaly patients
CyberKnife as a treatment for lung cancer
ESTRO 2010 - Snapshots from the conference
ESMO highlights from Prof Gordon McVie - his views on the science presented
The ESMO President discusses the congress and future plans for developing countries